Dean Foundation   Report issue

Foundation Phase 2 Phase 3
Founded: Madison WI United States (1986)

Organization Overview

First Clinical Trial
2001
NCT00035412
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Dean Foundation for Health, Research and Analysis

Active Ingredients

Drugs in Phase 3 Trials (1)

azithromycin (zithromax) (1 trial)

Drugs in Phase 2 Trials (1)

hypericum perforatum (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Compulsive Personality Disorder (Phase 2)

Disease (Phase 2)

Obsessive-Compulsive Disorder (Phase 2)

Phobia, Social (Phase 2)

Phobic Disorders (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2